Skip to main content
. 2011 Sep 23;20(24):4978–4990. doi: 10.1093/hmg/ddr433

Figure 8.

Figure 8.

rAAV6-delivered Dp116 does not protect myofibers from dystrophic turnover. mdx:utrn−/− mice were treated with rAAV6-Dp116 at 2 weeks of age. Quadriceps (bottom) and TA (top) were collected and analyzed for Dp116 expression via immunofluorescent staining. At 4 weeks post-injection (left), robust expression of Dp116 is observed. In contrast, Dp116 expression is nearly absent at 10 weeks post-injection (right).